Arvinas (ARVN) Change in Accured Expenses (2017 - 2026)

Arvinas' (ARVN) quarterly Change in Accured Expenses came in at -$6.8 million in Q1 2026, down 750.0% year-on-year from $1.0 million in Q1 2025, and down 142.5% quarter-over-quarter from $16.0 million in Q4 2025.

Arvinas (ARVN) Change in Accured Expenses (2017 - 2026) Analysis & Trends

Arvinas' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$6.8 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 750.0% year-over-year to -$6.8 million in Q1 2026; TTM through Mar 2026 was -$7.7 million, a 22.22% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 million, up 91.98% from the prior year.
  • Change in Accured Expenses retreated to -$6.8 million in Q1 2026 per ARVN's latest filing, from $16.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $25.2 million in Q4 2022 and bottomed at -$16.8 million in Q2 2025.
  • The 5-year median for Change in Accured Expenses is -$100000.0 (2025), against an average of $458823.5.
  • Across the five-year window, Change in Accured Expenses jumped 3750.0% in 2022 and slumped 1033.33% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at $25.2 million in 2022, then tumbled by 94.84% to $1.3 million in 2023, then slumped by 476.92% to -$4.9 million in 2024, then soared by 426.53% to $16.0 million in 2025, then slumped by 142.5% to -$6.8 million in 2026.
  • Per Business Quant, the three latest ARVN Change in Accured Expenses figures stand at -$6.8 million (Q1 2026), $16.0 million (Q4 2025), and -$100000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.13 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -16.82 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -16.74 Mn
10 Arvinas 519.68 Mn -95.22 Mn - -6.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.80 Mn
Mar 31, 2026 -6.80 Mn
Dec 31, 2025 16.00 Mn
Dec 31, 2025 16.00 Mn
Sep 30, 2025 -100,000.00
Sep 30, 2025 -100,000.00
Jun 30, 2025 -16.80 Mn
Jun 30, 2025 -16.80 Mn
Mar 31, 2025 -800,000.00
Mar 31, 2025 -800,000.00
Dec 31, 2024 -4.90 Mn
Dec 31, 2024 -4.90 Mn
Sep 30, 2024 -2.40 Mn
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 1.80 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 -15.70 Mn
Mar 31, 2024 -15.70 Mn
Dec 31, 2023 1.30 Mn
Dec 31, 2023 1.30 Mn